The mechanisms include vascular disease, hormonal imbalances (particularly reduced testosterone in men), psychological factors, and reduced physical stamina
Semaglutide, tirzepatide, and retatrutide representing mono-agonist, dual-agonist, and triple-agonist approaches respectively have been studied extensively in clinical trials focused on metabolic function and body composition
These distinct pathways suggest that concurrent use is unlikely to result in direct pharmacological interference
Dai H, Liang S, Shan D, Zhang Q, Li J, Xu Q, Wang C (2022) Efficient and simple simultaneous adsorption removal of multiple aflatoxins from various liquid foods